Company overview
ImmuneOnco Biopharmaceuticals (Shanghai) Co.,Ltd., founded in June 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early-stage biopharmaceutical company dedicated to development and commercialization of novel cancer immunotherapeutics that reverse cancer cell-induced immune inhibition and actively eradicate cancer cells.
News Center
-
09-292021ImmuneOnco won the "Top 20 Innovation and Entrepreneurship in Pudong New Area in 2020"On the September 29, 2021, Pudong New Area held commendation event for "2021 Outstanding Economic Contribution Enterpr......See details
-
09-282021ImmuneOnco sets up wholly-owned subsidiary—ImmuneOnco BioPharm (Shanghai) Co., Ltd.On September 28, ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as "ImmuneOnco") wholly-o......See details
-
09-062021ImmuneOnco：Clinical Research Application for IMM27M was accepted by the National Medical Products Administration (NMPA)On September 1, 2021, ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as "ImmuneOnco") ann......See details